Volume 28, No 5, May 2018

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 28 Issue 5, May 2018: 601-604

LETTERS TO THE EDITOR

Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types

Yanan Cao ^1,2, Weiwei Zhou ¹, Lin Li ¹, Jiaqian Wang ³, Zhibo Gao ³,Yiran Jiang ¹, Xiuli Jiang ¹, Aijing Shan ¹, Matthew H. Bailey ^4,5,Kuan-lin Huang ^4,5, Sam Q. Sun ^4,5, Michael D. McLellan ⁴,Beifang Niu ^4,6, Weiqing Wang ¹, Li Ding ^4,5,7 and Guang Ning ^1,2

¹ Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Key Laboratory for Endocrine Tumors, Rui-Jin Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, China; ² Laboratory of Endocrinology and Metabolism, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China; ³ YuceBio, Shenzhen, China; ⁴ McDonnell Genome Institute, Washington University, St. Louis, MO, USA; ⁵ Department of Medicine, Division of Oncology, Washington University, St. Louis, MO, USA; ⁶ Department of High-Performance Computing Technology and Application Development, Computer Network Information Center, Chinese Academy of Sciences, Beijing, China and ⁷ Siteman Cancer Center, Washington University, St. Louis, MO, USA Correspondence: These authors contributed equally to this work: Yanan Cao, WeiweiZhou, Lin Li, Jiaqian Wang, and Zhibo Gao.Yanan Cao (caoyanan@vip.sina.com) or Li Ding (lding@genome.wustl.edu) or Guang Ning (guangning@medmail.com.cn)

10.1038/s41422-018-0019-5

FULL TEXT | PDF

Browse 1369